Unaudited Condensed Consolidated Statements Of Stockholders’ Equity (USD $)	Total	Common stock	Additional paid-in capital	Unearned compensation ESOP	Retained earnings	Accumulated other comprehensive income (loss)
Balance at Sep. 30, 2013	$ 273,777,836	$ 227,522	$ 171,729,570	$ (6,480,949)	$ 110,141,286	$ (1,839,593)
Shares, outstanding at Sep. 30, 2013		22,752,214
Net income	5,955,133		0	0	5,955,133	0
Dividends paid, $0.10 and $0.20 per share in the YTD Mar 31, 2015 and YTD Sept 30, 2014, respectively	(4,171,876)		0	0	(4,171,876)	0
Change in unrealized (gain) loss on securities	1,085,458		0	0	0	1,085,458
Allocation of ESOP common stock	592,857		96,225	496,632	0	0
Effect of restricted stock awards	662,747		662,747	0	0	0
Stock option expense	291,512		291,512	0	0	0
Issuance of common stock in offering (in shares)		360,751
Issuance of common stock, restricted stock	0	3,608	(3,608)	0	0	0
Stock repurchased during period (in shares)	(4,851,577)
Repurchase of shares	(53,238,798)	(48,516)	(53,190,282)	0	0	0
Balance at Sep. 30, 2014	224,954,869	182,614	119,586,164	(5,984,317)	111,924,543	(754,135)
Shares, outstanding at Sep. 30, 2014		18,261,388
Net income	3,107,735		0	0	3,107,735	0
Dividends paid, $0.10 and $0.20 per share in the YTD Mar 31, 2015 and YTD Sept 30, 2014, respectively	(1,589,479)		0	0	(1,589,479)	0
Change in unrealized (gain) loss on securities	1,319,706		0	0	0	1,319,706
Allocation of ESOP common stock	561,259		128,135	433,124	0	0
Effect of restricted stock awards	397,623		397,623	0	0	0
Stock option expense	165,497		165,497	0	0	0
Issuance of common stock in offering (in shares)		1,316
Issuance of common stock, restricted stock	0	13	(13)	0	0	0
Stock repurchased during period (in shares)	(1,598,956)
Repurchase of shares	(17,671,524)	(15,990)	(17,655,534)	0	0	0
Balance at Mar. 31, 2015	$ 211,245,686	$ 166,637	$ 102,621,872	$ (5,551,193)	$ 113,442,799	$ 565,571
Shares, outstanding at Mar. 31, 2015		16,663,748